Following the success of our previous event in Zurich in October 2023, Baker McKenzie, IQVIA and Stifel have the pleasure of inviting you to a panel discussion focusing on the recent and  proposed changes to the pharma legislation and their impact on future strategic decisions and biotech dealmaking. This will be the second event in our series of joint events on Biotech Dealmaking. We will discuss the changes and new trends from a global perspective.

Speakers for the panel discussion regarding regulatory changes in Europe and their impact on market access include Cathrin Schäfer from BeiGene, Marlene Gyldmark from Idorsia Pharmaceuticals, Jennifer Ulbrich from F.Hoffmann-La Roche Ltd, Joerg Spang from IQVIA, and Els Janssens from Baker McKenzie. Speakers for the transactional panel on recent trends in biotech dealmaking and financing include Peter Louwagie from Genmab, David Veitch from Basilea, Nigel Sheail from Versant Ventures, Nicholas Moore and Stephanie Léouzon from Stifel and Julia Schieber from Baker McKenzie.

The panel discussion will be followed by a networking reception and apéro.

This seminar is free of charge to attend. Register by Wednesday, 29 May 2024. Registrations will be processed in order of receipt.

We look forward to welcoming you soon!

  • June 12, 2024 @ 2:00 pm
  • 4051 Basel
Event starts in
  • 00

  • 00

  • 00

Type of event
Contact Form